Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aeterna Zentaris (AEZS)

0.3571   0.007 (2.03%) 10-23 23:40
Open: 0.3542 Pre. Close: 0.35
High: 0.363 Low: 0.3456
Volume: 520,074 Market Cap: 22M
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The company is headquartered in Montreal, Quebec and currently employs 22 full-time employees. The firm operates through the biopharmaceutical segment. The firm is engaged in drug development activities and in the promotion of products for others. The firm's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The firm focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The firm's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.361 - 0.363 0.363 - 0.364
Low: 0.345 - 0.347 0.347 - 0.35
Close: 0.356 - 0.36 0.36 - 0.364

Technical analysis

as of: 2020-10-23 4:40:17 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.44     One year: 0.48
Support: Support1: 0.33    Support2: 0.27
Resistance: Resistance1: 0.38    Resistance2: 0.41
Pivot: 0.37
Moving Average: MA(5): 0.36     MA(20): 0.37
MA(100): 0.53     MA(250): 0.76
MACD: MACD(12,26): -0.01     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 26.17     %D(3): 29.09
RSI: RSI(14): 42.89
52-week: High: 1.54  Low: 0.33  Change(%): -64.6
Average Vol(K): 3-Month: 321069  10-Days: 80353

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AEZS has closed above bottom band by 23.6%. Bollinger Bands are 80.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to AEZS's normal range. The bands have been in this narrow range for 66 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 22 Oct 2020
Aeterna Zentaris Inc. (AEZS): Significant Improvements, Worth Considering - Stocks Register

Thu, 22 Oct 2020
We Analyzed the Future Direction of Aeterna Zentaris Inc. (AEZS), Here is What We Found - The News Heater

Fri, 09 Oct 2020
The Rosen Law Firm, PA and Glancy Prongay & Murray LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Aeterna Zentaris, Inc. - AEZS - PRNewswire

Fri, 09 Oct 2020
Aeterna Zentaris Inc. [AEZS] Revenue clocked in at $1.50 million, down -58.65% YTD: What’s Next? - The DBT News

Thu, 08 Oct 2020
Aeterna Zentaris Inc. (AEZS) last month performance of -1.34% certainly makes it a sizzling prospect - News Daemon

Thu, 08 Oct 2020
Riding the Trend or Protecting Profits | Aeterna Zentaris Inc. (AEZS) - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 63
Shares Float (M) 24
% Held by Insiders 0.03
% Held by Institutions 10.82
Shares Short (K) 1,820
Shares Short P. Month (K) 1,700

Stock Financials

EPS -0.205
EPS Est This Year -1.020
EPS Est Next Year -0.290
Book Value (p.s.) 0.040
Profit Margin -274.71
Operating Margin -490.20
Return on Assets (ttm) -23.3
Return on Equity (ttm)
Qtrly Rev. Growth -64.9
Gross Profit (p.s.) 0.002
Sales Per Share 0.023
EBITDA (p.s.) -0.114
Qtrly Earnings Growth
Operating Cash Flow (M) -10
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -1.74
PEG Ratio
Price to Book value 8.93
Price to Sales 15.33
Price to Cash Flow -2.15

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.